Alvotech

Businesspeople reaching agreement
Pharma

Partners Alvotech, Teva eye 2026 Eylea biosimilar launch

The Eylea biosim has been under FDA review for much of this year. Back in February, the companies said they expected a decision by the end of 2025.
Eric Sagonowsky Dec 19, 2025 10:40am
red light stop light street traffic signal

Alvotech plant issues trigger another FDA biosimilar rejection

Nov 4, 2025 7:40am
launch button

Teva and Alvotech's Humira biosimilar finally snags FDA approval

Feb 23, 2024 9:00pm
world global globe ex-US country map regions

Alvotech plots upcoming overseas Stelara biosim launches

Feb 16, 2024 7:20am
Letter opening FDA clinical hold

FDA doles out yet another Form 483 to troubled Alvotech

Jan 22, 2024 9:03am
Image of a neon sign with the word no lit up next to an unlit yes

FDA plant inspection foils another Alvotech biosimilar approval

Oct 12, 2023 10:35am